Siemens Energy raises 2028 targets-May 2024-www.financetom.com

Siemens Energy raises 2028 targets

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Siemens Energy raises 2028 targets

Nov 12, 2024 9:00 PM

FRANKFURT, Nov 12 (Reuters) - Siemens Energy

on Tuesday raised its targets for 2028, now expecting a profit

margin of 10-12% compared with at least 8% previously.

Previous page： Lithium Americas Closes US$625 Million Investment Agreement with General Motors; Shares Up 4% in U.S. Pre-Market Next page：

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Lithium Americas Closes US$625 Million Investment Agreement with General Motors; Shares Up 4% in U.S. Pre-Market

Dec 23, 2024

08:07 AM EST, 12/23/2024 (MT Newswires) -- Lithium Americas ( LAC ) jumped 4.4% at last look Monday in NYSE pre-market trading as it closed a US$625 million investment agreement with General Motors Holdings over the Thacker Pass lithium project in Nevada. The joint venture agreement granted the automaker a 38% interest in Thacker Pass. Lithium Americas ( LAC )...

Dec 23, 2024

...

US FDA sends warning letter to Viatris over India manufacturing facility

Dec 23, 2024

Dec 23 (Reuters) - Viatris ( VTRS ) said on Monday it has received a warning letter from the U.S. Food and Drug Administration after an inspection at its oral finished dose manufacturing facility in Indore, India earlier this year. ...

Cytokinetics Says European Regulator Validated its Application for Cardiomyopathy Drug Candidate

Dec 23, 2024

08:03 AM EST, 12/23/2024 (MT Newswires) -- Cytokinetics ( CYTK ) said Monday that the European Medicines Agency has validated its marketing authorization application for aficamten as as potential treatment for obstructive hypertrophic cardiomyopathy. The application will now be reviewed by the agency's Committee for Medicinal Products for Human Use. The application is supported by the results of a 24-week...